山楂叶总黄酮治疗多囊卵巢综合征的研究进展
Research Progress of Hawthorn Leaf Flavonoids in the Treatment of Polycystic Ovary Syndrome
DOI: 10.12677/acm.2025.15113364, PDF,   
作者: 李东琪:黑龙江中医药大学研究生院,黑龙江 哈尔滨;匡洪影*:黑龙江中医药大学附属第一医院妇科二科,黑龙江 哈尔滨
关键词: 多囊卵巢综合征山楂叶总黄酮炎症糖脂代谢肠道菌群Polycystic Ovary Syndrome Hawthorn Leaf Flavonoids Inflammation Glycolipid Metabolism Intestinal Bacteria
摘要: 多囊卵巢综合征(PCOS)是育龄期女性常见的生殖内分泌疾病,其发病机制尚不清楚,但已证实与遗传、代谢、内分泌和环境因素存在密切联系。目前临床上仍缺乏治疗PCOS的特异性药物,西医治疗多以干预生活方式和对症治疗为核心,而长期激素干预易加重机体代谢紊乱。相比之下,中医药的多靶点干预优势显著。山楂叶总黄酮作为中药山楂叶核心活性成分,具有抗炎、抗氧化、抗凋亡、改善糖脂代谢以及性激素水平等多种药理作用。已有研究表明,该成分可缓解PCOS患者的临床症状,例如纠正糖脂代谢紊乱、减轻肥胖程度、改善慢性炎症状态,调节肠道菌群结构等。但目前为止,其发挥作用的确切机制仍未完全明晰。基于此,本研究以PCOS的多种病理途径为切入点,深入探究山楂叶总黄酮的作用机制,以期为该成分的临床应用及相关药物研发提供理论参考。
Abstract: Polycystic ovary syndrome (PCOS) is a common reproductive endocrine disease in women of child-bearing age. Its pathogenesis is not yet known, but it has been confirmed that it has a close relationship with genetic, metabolic, endocrine and environmental factors. Currently, there is still a lack of specific drugs for the treatment of PCOS in clinical practice. Western medicine treatment is mostly based on lifestyle intervention and symptomatic treatment. Long-term hormone intervention can easily aggravate the body’s metabolic disorders. In contrast, the multi-target intervention advantages of traditional Chinese medicine are significant. As the core active hawthorn leaf flavonoids in traditional Chinese medicine, total flavonoids have various pharmacological effects such as anti-inflammatory, antioxidant, anti-apoptotic, improving glycolipid metabolism, and sex hormone levels. Studies have shown that this ingredient can alleviate the clinical symptoms of PCOS patients, such as correcting glycolipid metabolism disorders, reducing obesity, improving chronic inflammation, and regulating the intestinal microbial structure. But so far, the exact mechanism of its function is not fully understood. Based on this, this study takes the various pathological pathways of PCOS as the entry point and deeply explores the mechanism of action of total flavonoids in hawthorn leaves, in order to provide theoretical reference for the clinical application of this ingredient and the development of related drugs.
文章引用:李东琪, 匡洪影. 山楂叶总黄酮治疗多囊卵巢综合征的研究进展[J]. 临床医学进展, 2025, 15(11): 2410-2415. https://doi.org/10.12677/acm.2025.15113364

参考文献

[1] Wang, J., Wu, D., Guo, H. and Li, M. (2019) Hyperandrogenemia and Insulin Resistance: The Chief Culprit of Polycystic Ovary Syndrome. Life Sciences, 236, Article ID: 116940. [Google Scholar] [CrossRef] [PubMed]
[2] Stener-Victorin, E. and Deng, Q. (2021) Epigenetic Inheritance of Polycystic Ovary Syndrome—Challenges and Opportunities for Treatment. Nature Reviews Endocrinology, 17, 521-533. [Google Scholar] [CrossRef] [PubMed]
[3] 国家药典委员会. 中华人民共和国药典一部2020年版[M]. 北京: 中国医药科技出版社, 2020: 1902.
[4] Duan, L., Xiong, H., Du, Y., Wang, Z., Li, Y., Zhao, S., et al. (2022) High‐Throughput LC-MS Method for the Rapid Characterisation and Comparative Analysis of Multiple Ingredients of Four Hawthorn Leaf Extracts. Phytochemical Analysis, 33, 635-643. [Google Scholar] [CrossRef] [PubMed]
[5] Xu, Y., Deng, T., Xie, L., Qin, T. and Sun, T. (2022) Neuroprotective Effects of Hawthorn Leaf Flavonoids in Aβ25-35-Induced Alzheimer’s Disease Model. Phytotherapy Research, 37, 1346-1365. [Google Scholar] [CrossRef] [PubMed]
[6] 王雅楠, 黄姗, 尹玉云, 等. 山楂叶类保健食品中总黄酮的提取及抗氧化活性研究[J]. 食品安全质量检测学报, 2024, 15(13): 89-98.
[7] Liu, Z., Gao, T., Chang, H., Xu, Y., Wang, L., Wang, X., et al. (2025) Hawthorn Leaf and Its Extract Alleviate High-Fat Diet-Induced Obesity and Modulate Gut Microbiome in Mice. Current Research in Food Science, 10, Article ID: 101025. [Google Scholar] [CrossRef] [PubMed]
[8] Bai, X., Wang, S., Shu, L., Cao, Q., Hu, H., Zhu, Y., et al. (2024) Hawthorn Leaf Flavonoids Alleviate the Deterioration of Atherosclerosis by Inhibiting SCAP-SREBP2-LDLR Pathway through sPLA2-Ⅱa Signaling in Macrophages in Mice. Journal of Ethnopharmacology, 327, Article ID: 118006. [Google Scholar] [CrossRef] [PubMed]
[9] Di Lorenzo, M., Cacciapuoti, N., Lonardo, M.S., Nasti, G., Gautiero, C., Belfiore, A., et al. (2023) Pathophysiology and Nutritional Approaches in Polycystic Ovary Syndrome (PCOS): A Comprehensive Review. Current Nutrition Reports, 12, 527-544. [Google Scholar] [CrossRef] [PubMed]
[10] 潘紫萌, 李婧, 孙畅, 等. 痰湿证多囊卵巢综合征患者的胰岛素敏感性及胰岛β细胞功能与临床特征的相关性分析[J]. 中华中医药杂志, 2022, 37(10): 5950-5956.
[11] Brown, G.C. and Heneka, M.T. (2024) The Endotoxin Hypothesis of Alzheimer’s Disease. Molecular Neurodegeneration, 19, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[12] Yuan, X., Wang, R., Han, B., Sun, C., Chen, R., Wei, H., et al. (2022) Functional and Metabolic Alterations of Gut Microbiota in Children with New-Onset Type 1 Diabetes. Nature Communications, 13, Article No. 6356. [Google Scholar] [CrossRef] [PubMed]
[13] Entezari, M., Hashemi, D., Taheriazam, A., Zabolian, A., Mohammadi, S., Fakhri, F., et al. (2022) AMPK Signaling in Diabetes Mellitus, Insulin Resistance and Diabetic Complications: A Pre-Clinical and Clinical Investigation. Biomedicine & Pharmacotherapy, 146, Article ID: 112563. [Google Scholar] [CrossRef] [PubMed]
[14] Han, Y., Wu, H., Sun, S., Zhao, R., Deng, Y., Zeng, S., et al. (2023) Effect of High Fat Diet on Disease Development of Polycystic Ovary Syndrome and Lifestyle Intervention Strategies. Nutrients, 15, Article 2230. [Google Scholar] [CrossRef] [PubMed]
[15] 蒋玲玲, 阮祥燕, 李妍秋, 等. 多囊卵巢综合征患者体成分对肝、肾功能和血脂的影响[J]. 首都医科大学学报, 2024, 45(4): 623-628.
[16] Hu, H., Weng, J., Cui, C., Tang, F., Yu, M., Zhou, Y., et al. (2022) The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID: 3033311. [Google Scholar] [CrossRef] [PubMed]
[17] 海杰, 陈振东, 张宗博, 等. 山楂叶总黄酮干预非酒精性脂肪性肝病作用机制的研究进展[J]. 中成药, 2025, 47(6): 1937-1942.
[18] Oussaada, S.M., Kilicarslan, M., de Weijer, B.A., Gilijamse, P.W., Şekercan, A., Virtue, S., et al. (2024) Tissue-Specific Inflammation and Insulin Sensitivity in Subjects with Obesity. Diabetes Research and Clinical Practice, 211, Article ID: 111663. [Google Scholar] [CrossRef] [PubMed]
[19] Rudrapatna, S., Bhatt, M., Wang, K., Bierbrier, R., Wang, P., Banfield, L., et al. (2019) Obesity and Muscle‐Macrophage Crosstalk in Humans and Mice: A Systematic Review. Obesity Reviews, 20, 1572-1596. [Google Scholar] [CrossRef] [PubMed]
[20] 商婷婷, 庄子荀, 马桦, 等. 从“脾为之卫”理论探析巨噬细胞极化在PCOS慢性低度炎症中的作用[J]. 中国实验方剂学杂志, 2024, 30(9): 211-218.
[21] Caratti, G., Stifel, U., Caratti, B., Jamil, A.J.M., Chung, K., Kiehntopf, M., et al. (2023) Glucocorticoid Activation of Anti-Inflammatory Macrophages Protects against Insulin Resistance. Nature Communications, 14, Article No. 2271. [Google Scholar] [CrossRef] [PubMed]
[22] 王敏, 王子依, 蒋泽祯, 等. 脂肪酸摄入与肥胖的相关性研究进展[J]. 中国食品学报, 2025, 25(7): 392-404.
[23] 罗雯静, 董显文, 赵巧素, 等. 维生素D调控巨噬细胞极化对肝细胞脂质代谢的作用及机制[J]. 营养学报, 2024, 46(2): 139-145.
[24] Glass, C.K. and Olefsky, J.M. (2012) Inflammation and Lipid Signaling in the Etiology of Insulin Resistance. Cell Metabolism, 15, 635-645. [Google Scholar] [CrossRef] [PubMed]
[25] 苗光新, 李蒙蒙, 吴晓光. 山楂叶总黄酮对脑缺血大鼠Caspase-3蛋白及炎症因子表达的影响[J]. 中国老年学杂志, 2019, 39(10): 2487-2490.
[26] 严茂祥, 陈芝芸, 何蓓晖. 山楂叶总黄酮对非酒精性脂肪性肝炎大鼠肝组织NF-κB及其抑制物表达的影响[J]. 中华中医药杂志, 2009, 24(2): 139-143.
[27] Salehi, S., Allahverdy, J., Pourjafar, H., Sarabandi, K. and Jafari, S.M. (2024) Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy. Probiotics and Antimicrobial Proteins, 16, 1553-1565. [Google Scholar] [CrossRef] [PubMed]
[28] Sun, Y., Gao, S., Ye, C. and Zhao, W. (2023) Gut Microbiota Dysbiosis in Polycystic Ovary Syndrome: Mechanisms of Progression and Clinical Applications. Frontiers in Cellular and Infection Microbiology, 13, Article 1142041. [Google Scholar] [CrossRef] [PubMed]
[29] Guo, X., Okpara, E.S., Hu, W., Yan, C., Wang, Y., Liang, Q., et al. (2022) Interactive Relationships between Intestinal Flora and Bile Acids. International Journal of Molecular Sciences, 23, Article 8343. [Google Scholar] [CrossRef] [PubMed]
[30] Qi, X., Yun, C., Pang, Y. and Qiao, J. (2021) The Impact of the Gut Microbiota on the Reproductive and Metabolic Endocrine System. Gut Microbes, 13, Article ID: 1894070. [Google Scholar] [CrossRef] [PubMed]
[31] 王雨珊, 刘旺景. 植物源性黄酮类化合物介导微生物保护肠道屏障的机制[J/OL]. 畜牧兽医学报: 1-17.
https://link.cnki.net/urlid/11.1985.S.20250708.1558.002, 2025-09-20.